Eli Lilly and Company, a pharmaceutical manufacturer, is releasing a new generic insulin product that is the same product as name-brand Humalog but will cost half as much.
One 100 mg vial of Insulin Lispro will cost $137.35, half the price of name-brand Humalog. Each vial lasts 28 days.
According to a press release from the company, the new version is an attempt to help those buy insulin who can’t afford the name-brand.
“For people with diabetes, a lower-priced insulin can serve as a bridge that addresses gaps in the system until a more sustainable model is achieved,” said Eli Lilly and Company CEO David Ricks in the release.
The almost $140 price tag for a month's supply of insulin is still higher than the estimated $48 to $71 it costs to produce a year's supply of insulin, according to a study done by BMJ Global Health.
Like what you're reading? Support independent, award-winning college journalism on this site. Donate here.
More in News
The two tickets, Bridge and Vision IUSG, answered questions before next week's election.
The survey will gauge students’ experiences and knowledge of campus resources.
The purpose is to teach attendees how to research and make Wikipedia edits.